Variables | Antipyretic; Analgesic; | Psychotropic drugs | Adrenal cortical hormones | Antibiotics | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-inflammatory drugs | ||||||||||||||||
Mean | SD | Test statistics (df) | P-Value | Mean | SD | Test statistics (df) | P-Value | Mean | SD | Test statistics (df) | P-Value | Mean | SD | Test statistics (df) | P-Value | |
Pharmacy characteristics | ||||||||||||||||
Sex of pharmacist | ||||||||||||||||
Male | 9.86 | 9.46 | Z = −11.6574 | <.0001† | 0.82 | 2.35 | Z = 4.6 | <.0001† | 0.29 | 0.71 | Z = −3.3 | 0.0021† | 6.77 | 30.87 | Z = 7.9 | <.0001† |
Female | 9.03 | 6.46 | 0.91 | 2.47 | 0.28 | 0.68 | 7.24 | 8.71 | ||||||||
Age of pharmacist (years) | ||||||||||||||||
≤45 | 9.20 | 11.17 | X2(3) = 382.8 | <.0001a | 0.95 | 2.63 | X2(3) = 207.2 | <.0001a | 0.32 | 0.73 | X2(3) = 85.1 | <.0001a | 8.90 | 32.82 | X2(3) = 378.3 | <.0001a |
46–55 | 8.72 | 5.99 | 0.98 | 2.35 | 0.26 | 0.55 | 7.00 | 7.96 | ||||||||
56–65 | 9.30 | 5.88 | 0.89 | 2.68 | 0.26 | 0.60 | 6.01 | 9.07 | ||||||||
≥66 | 10.75 | 7.04 | 0.60 | 1.83 | 0.30 | 0.87 | 5.44 | 26.32 | ||||||||
Length of operation | ||||||||||||||||
≤12 months | 9.94 | 15.77 | X2(2) = 1.4 | 0.3231a | 0.92 | 2.67 | X2(2) = 8.2 | 0.0109a | 0.35 | 0.96 | X2(2) = 18.4 | <.0001a | 10.45 | 56.56 | X2(2) = 173.7 | <.0001a |
13–24 months | 9.64 | 6.25 | 0.86 | 2.02 | 0.33 | 0.78 | 7.99 | 8.58 | ||||||||
≤25 months | 9.32 | 5.86 | 0.86 | 2.41 | 0.27 | 0.62 | 6.17 | 7.66 | ||||||||
Separation of drug prescribing and dispensing | ||||||||||||||||
Exception | 15.21 | 6.31 | Z = 18.5 | <.0001† | 0.39 | 1.08 | Z = −15.2 | <.0001† | 1.09 | 1.55 | Z = 14.0 | <.0001† | 6.01 | 8.81 | Z = 2.3 | 0.0232† |
Application | 9.34 | 8.11 | 0.88 | 2.42 | 0.27 | 0.66 | 7.03 | 22.91 | ||||||||
Period of exclusion for reformed program | ||||||||||||||||
≤18 months | 9.36 | 8.11 | Z = 16.8 | <.0001† | 0.87 | 2.42 | Z = −14.1 | <.0001† | 0.28 | 0.67 | Z = 12.2 | <.0001† | 7.02 | 22.87 | Z = 2.8 | 0.0057† |
≥19 months | 15.69 | 5.63 | 0.34 | 1.12 | 1.10 | 1.57 | 5.76 | 3.61 | ||||||||
Regional characteristics | ||||||||||||||||
Region | ||||||||||||||||
Metropolitan | 9.12 | 6.23 | Z = −10.5 | <.0001† | 0.86 | 2.60 | Z = −8.1 | <.0001† | 0.26 | 0.63 | Z = −11.3 | <.0001† | 7.00 | 19.34 | Z = −2.0 | 0.0404† |
Non-metropolitan | 9.77 | 9.61 | 0.88 | 2.20 | 0.32 | 0.76 | 7.02 | 25.61 | ||||||||
Total number of clinics in regions with pharmacies | ||||||||||||||||
≤60 | 9.53 | 6.19 | Z = −7.5 | <.0001† | 0.86 | 2.44 | Z = −3.1 | 0.0020† | 0.29 | 0.71 | Z = −6.5 | <.0001† | 6.99 | 16.42 | Z = −3.7 | 0.† |
≥61 | 9.21 | 12.1 | 0.89 | 2.29 | 0.27 | 0.66 | 7.05 | 35.20 | ||||||||
Total number of pharmacies in region with pharmacies | ||||||||||||||||
≤45 | 9.45 | 6.20 | Z = −2.2 | 0.0296† | 0.88 | 2.57 | Z = 0.2 | 0.8213† | 0.30 | 0.69 | Z = −9.2 | <.0001† | 7.30 | 16.90 | Z = −13.3 | <.0001† |
≥46 | 9.45 | 10.93 | 0.85 | 2.06 | 0.26 | 0.71 | 6.44 | 31.08 | ||||||||
Average per capita income in regions with pharmacies | ||||||||||||||||
≤38 million KRW | 9.77 | 9.48 | Z = −9.2 | <.0001† | 0.87 | 2.22 | Z = −9.6 | <.0001† | 0.29 | 0.69 | Z = −4.5 | <.0001† | 6.55 | 25.65 | Z = 11.3 | <.0001† |
≥39 million KRW | 9.09 | 6.23 | 0.87 | 2.59 | 0.28 | 0.71 | 7.52 | 18.92 | ||||||||
Total | 9.40 | 8.10 | 0.90 | 2.40 | 0.30 | 0.70 | 7.00 | 22.70 |